Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2015

Open Access 01-12-2015 | Research article

Lack of “obesity paradox” in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysis

Authors: Ibrahim Akin, Henrik Schneider, Christoph A. Nienaber, Werner Jung, Mike Lübke, Andreas Rillig, Uzair Ansari, Nina Wunderlich, Ralf Birkemeyer

Published in: BMC Cardiovascular Disorders | Issue 1/2015

Login to get access

Abstract

Background

Studies have associated obesity with better outcomes in comparison to non-obese patients after elective and emergency coronary revascularization. However, these findings might have been influenced by patient selection. Therefore we thought to look into the obesity paradox in a consecutive network STEMI population.

Methods

The database of two German myocardial infarction network registries were combined and data from a total of 890 consecutive patients admitted and treated for acute STEMI including cardiogenic shock and cardiopulmonary resuscitation according to standardized protocols were analyzed. Patients were categorized in normal weight (≤24.9 kg/m2), overweight (25-30 kg/m2) and obese (>30 kg/m2) according to BMI.

Results

Baseline clinical parameters revealed a higher comorbidity index for overweight and obese patients; 1-year follow-up comparison between varying groups revealed similar rates of all-cause death (9.1 % vs. 8.3 % vs. 6.2 %; p = 0.50), major adverse cardiac and cerebrovascular [MACCE (15.1 % vs. 13.4 % vs. 10.2 %; p = 0.53)] and target vessel revascularization in survivors [TVR (7.0 % vs. 5.0 % vs. 4.0 %; p = 0.47)] with normal weight when compared to overweight or obese patients. These results persisted after risk-adjustment for heterogeneous baseline characteristics of groups. An analysis of patients suffering from cardiogenic shock showed no impact of BMI on clinical endpoints.

Conclusion

Our data from two network systems in Germany revealed no evidence of an “obesity paradox”in an all-comer STEMI population including patients with cardiogenic shock.
Literature
1.
go back to reference Garrison RJ, Higgins MW, Kannel WB. Obesity and coronary heart disease. Curr Opin Lipidol. 1996;4:199–202.CrossRef Garrison RJ, Higgins MW, Kannel WB. Obesity and coronary heart disease. Curr Opin Lipidol. 1996;4:199–202.CrossRef
2.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, Nishkanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, Nishkanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.CrossRefPubMed
3.
go back to reference Minutello RM, Chou ET, Hong MK, Bergman G, Parikh M, Iacovone F, et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol. 2004;93:1229–32.CrossRefPubMed Minutello RM, Chou ET, Hong MK, Bergman G, Parikh M, Iacovone F, et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol. 2004;93:1229–32.CrossRefPubMed
4.
go back to reference Gruberg L, Weissman NJ, Waksman R, Fuch S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am CollCardiol. 2002;39:578–84.CrossRef Gruberg L, Weissman NJ, Waksman R, Fuch S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am CollCardiol. 2002;39:578–84.CrossRef
5.
go back to reference Powell BD, Lennon RJ, Lerman A, Bell MR, Berger PB, Higano ST, et al. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol. 2003;91:472–6.CrossRefPubMed Powell BD, Lennon RJ, Lerman A, Bell MR, Berger PB, Higano ST, et al. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol. 2003;91:472–6.CrossRefPubMed
6.
go back to reference Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996;78:642–6.CrossRefPubMed Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996;78:642–6.CrossRefPubMed
7.
go back to reference Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002;90:42–5.CrossRefPubMed Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol. 2002;90:42–5.CrossRefPubMed
8.
go back to reference Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–12.CrossRefPubMedPubMedCentral Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–12.CrossRefPubMedPubMedCentral
9.
go back to reference Li Y, Wu C, Sun Y, Jiang D, Zhang B, Ren L, et al. Obesity paradox: clinical benefits not observed in obese patients with ST-segment elevation myocardial infarction: a multicenter, prospective, cohort study of the northern region of China. Int J Cardiol. 2013;168:2949–50.CrossRefPubMed Li Y, Wu C, Sun Y, Jiang D, Zhang B, Ren L, et al. Obesity paradox: clinical benefits not observed in obese patients with ST-segment elevation myocardial infarction: a multicenter, prospective, cohort study of the northern region of China. Int J Cardiol. 2013;168:2949–50.CrossRefPubMed
10.
go back to reference Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72:521–5.CrossRefPubMed Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circ J. 2008;72:521–5.CrossRefPubMed
11.
go back to reference HealthOrganization W. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity, June 3–5, 1997. WHO Technical Series No. 894. Geneva, Switzerland: World Health Organization; 2000. HealthOrganization W. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity, June 3–5, 1997. WHO Technical Series No. 894. Geneva, Switzerland: World Health Organization; 2000.
12.
go back to reference National Institutes ofHealth. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998;6:51S–209S.CrossRef National Institutes ofHealth. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res. 1998;6:51S–209S.CrossRef
13.
go back to reference The GUSTO Investigators. An interventional randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–82.CrossRef The GUSTO Investigators. An interventional randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–82.CrossRef
14.
go back to reference Serebruany VL, Atar D. Assessment of bleeding events in clinical trials–proposal of a new classification. Am J Cardiol. 2007;99:288–90.CrossRefPubMed Serebruany VL, Atar D. Assessment of bleeding events in clinical trials–proposal of a new classification. Am J Cardiol. 2007;99:288–90.CrossRefPubMed
15.
go back to reference Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRefPubMed Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.CrossRefPubMed
16.
go back to reference Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–51.CrossRefPubMed Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–51.CrossRefPubMed
17.
go back to reference Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8:200.CrossRefPubMedPubMedCentral Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008;8:200.CrossRefPubMedPubMedCentral
18.
go back to reference Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–105.CrossRefPubMed Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–105.CrossRefPubMed
19.
go back to reference Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.CrossRefPubMed Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–9.CrossRefPubMed
20.
go back to reference Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10 suppl 2:97–104.CrossRef Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res. 2002;10 suppl 2:97–104.CrossRef
21.
go back to reference Oreopoulos A, Padwal R, Norris C, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality post coronary revascularization: a meta-analysis. Obesity. 2008;16:442–50.CrossRefPubMed Oreopoulos A, Padwal R, Norris C, Pretorius V, Kalantar-Zadeh K. Effect of obesity on short- and long-term mortality post coronary revascularization: a meta-analysis. Obesity. 2008;16:442–50.CrossRefPubMed
22.
go back to reference Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.CrossRefPubMed Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78.CrossRefPubMed
23.
go back to reference Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30:2584–92.CrossRefPubMedPubMedCentral Oreopoulos A, McAlister FA, Kalantar-Zadeh K, Padwal R, Ezekowitz JA, Sharma AM, et al. The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J. 2009;30:2584–92.CrossRefPubMedPubMedCentral
24.
go back to reference Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971–5.PubMed Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971–5.PubMed
25.
go back to reference Schunkert MD, Harrell L, Palacios IF. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am CollCardiol. 1999;34:40–8.CrossRef Schunkert MD, Harrell L, Palacios IF. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am CollCardiol. 1999;34:40–8.CrossRef
26.
go back to reference Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677–85.CrossRefPubMed Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677–85.CrossRefPubMed
27.
go back to reference Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L. Body mass index and mortality among non-smoking older persons: the Framingham Heart Study. JAMA. 1988;259:1520–4.CrossRefPubMed Harris T, Cook EF, Garrison R, Higgins M, Kannel W, Goldman L. Body mass index and mortality among non-smoking older persons: the Framingham Heart Study. JAMA. 1988;259:1520–4.CrossRefPubMed
28.
go back to reference Lee IM, Manson JE, Hennekens CH, Paffenbarger Jr RS. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA. 1993;270:2823–8.CrossRefPubMed Lee IM, Manson JE, Hennekens CH, Paffenbarger Jr RS. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA. 1993;270:2823–8.CrossRefPubMed
29.
go back to reference Adams KF, Schatzkin A, Harris B, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRefPubMed Adams KF, Schatzkin A, Harris B, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRefPubMed
30.
go back to reference Holmes Jr DR, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am CollCardiol. 1999;33:412–9.CrossRef Holmes Jr DR, White HD, Pieper KS, Ellis SG, Califf RM, Topol EJ. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am CollCardiol. 1999;33:412–9.CrossRef
31.
go back to reference Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The CADILLAC risk score. J Am CollCardiol. 2005;45:1397–405.CrossRef Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction. The CADILLAC risk score. J Am CollCardiol. 2005;45:1397–405.CrossRef
32.
go back to reference Niraj A, Pradahan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: ‘obesity paradox’ revisited. Clin Cardiol. 2007;30:391–6.CrossRefPubMed Niraj A, Pradahan J, Fakhry H, Veeranna V, Afonso L. Severity of coronary artery disease in obese patients undergoing coronary angiography: ‘obesity paradox’ revisited. Clin Cardiol. 2007;30:391–6.CrossRefPubMed
33.
go back to reference Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the ‘obesity paradox’ in the Get with the Guidelines database. Am J Cardiol. 2007;100:1331–5.CrossRefPubMed Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the ‘obesity paradox’ in the Get with the Guidelines database. Am J Cardiol. 2007;100:1331–5.CrossRefPubMed
34.
go back to reference Reiner A, Siscovick D, Rosendaal F. Hemostatic risk factors and arterial thrombotic disease. Thromb Haemost. 2001;85:584–95.PubMed Reiner A, Siscovick D, Rosendaal F. Hemostatic risk factors and arterial thrombotic disease. Thromb Haemost. 2001;85:584–95.PubMed
35.
go back to reference Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Hernandez-Antolin R. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol. 2004;16:169–74.PubMed Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Hernandez-Antolin R. Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted? J Invasive Cardiol. 2004;16:169–74.PubMed
36.
go back to reference Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N. Impact of body mass index on platelet aggregation after administration of a high dose of 600 mg of clopidogrel before percutaneous coronary intervention. Am J Cardiol. 2007;100:203–5.CrossRefPubMed Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N. Impact of body mass index on platelet aggregation after administration of a high dose of 600 mg of clopidogrel before percutaneous coronary intervention. Am J Cardiol. 2007;100:203–5.CrossRefPubMed
37.
go back to reference Panagotiakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 2005;183:308–15.CrossRef Panagotiakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis. 2005;183:308–15.CrossRef
38.
go back to reference Sonnenberg G, Kraower G, Kissebah A. A novel pathway to the manifestation of metabolic syndrome. Obes Res. 2004;12:180–6.CrossRefPubMed Sonnenberg G, Kraower G, Kissebah A. A novel pathway to the manifestation of metabolic syndrome. Obes Res. 2004;12:180–6.CrossRefPubMed
39.
go back to reference Tremblay A, Bandi V. Impact of body mass index on outcomes following critical care. Chest. 2003;123:1202–7.CrossRefPubMed Tremblay A, Bandi V. Impact of body mass index on outcomes following critical care. Chest. 2003;123:1202–7.CrossRefPubMed
Metadata
Title
Lack of “obesity paradox” in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysis
Authors
Ibrahim Akin
Henrik Schneider
Christoph A. Nienaber
Werner Jung
Mike Lübke
Andreas Rillig
Uzair Ansari
Nina Wunderlich
Ralf Birkemeyer
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2015
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-015-0065-6

Other articles of this Issue 1/2015

BMC Cardiovascular Disorders 1/2015 Go to the issue